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Abstract 
Calorie restriction (CR) without malnutrition is the most robust intervention 
to slow aging and extend healthy lifespan in experimental model organisms. 
Several metabolic and molecular adaptations have been hypothesized to play 
a role in mediating the anti-­‐ aging effects of CR, including enhanced stress 
resistance, reduced oxidative stress and several neuroendocrine 
modifications. However, little is known about the independent effect of 
circulating factors in modulating key molecular pathways. In this study, we 
used sera collected from individuals practicing long-­‐ term CR and from age-­‐  
and sex-­‐ matched individuals on a typical US diet to culture human primary 
fibroblasts and assess the effects on gene expression and stress resistance. We 
show that treatment of cultured cells with CR sera caused increased 
expression of stress-­‐ response genes and enhanced tolerance to oxidants. 
These cellular and molecular adaptations mirror some of the key effects of 
CR in animals, and further suggest that circulating factors contribute to the 
CR-­‐ mediated protection against oxidative stress and stress-­‐ response in 
humans as well. 
Anorexia nervosa (AN) is an excessive form of calorie restriction associated 
with pathological weight loss and alterations of the immune system. 
However, AN patients seem to be protected from common viral infections. In 
this study, we investigated the metabolic and molecular adaptations induced 
by sustained extreme CR in the peripheral blood mononuclear cells (PBMCs) 
of patients with restrictive alimentary AN. Compared with controls, AN 
patients had significantly fewer leucocytes, lymphocytes and NK cells, lower 
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serum concentrations of leptin, IGF-1 and sTNFR1, and higher levels of 
adiponectin, sCD40L and sICAM-1 (p < 0.05). IL-1β, TNFα, and IL-6 
produced by PBMC cultured with autologous serum for 48 h were 
significantly lower in AN patients than in controls (p < 0.01). Moreover, 
glycolysis and mitochondrial respiration were lower, and the antioxidant 
transcriptional profile was higher in the PBMCs of AN patients. Fibroblasts 
cultured in serum from AN patients showed a 24% increase in resistance to 
H2O2 damage. 
In conclusion, extreme CR in AN patients is associated with a reduction in 
several immune cell populations, but with higher antioxidant potential, stress 
resistance and an anti-inflammatory status. 
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1. INTRODUCTION 
1.1 Calorie Restriction 
Calorie Restriction (CR) with adequate nutrition improves multiple 
parameters of health and extends lifespan. CR is defined as a dietary 
intervention where calorie intake is reduced below the usual ad libitum intake 
while adequate intake of proteins and micronutrients are maintained at 
sufficient levels to avoid malnutrition. The effects of CR on disease risk and 
life expectancy is widely studied in model organisms and humans. 
1.1.1 Calorie Restriction in model organisms 
The first evidence that CR can extend the mean and maximum lifespan of 
rats was published in 1935 by McCay et al. (1935). Subsequent data have 
shown that CR slows aging and increases maximum lifespan in different 
species, including yeast, fruit flies, worms, spiders, fish, mice and dogs 
(Weindruch and Walford 1988, Masoro 2005). Invertebrate model organisms 
(i.e., yeast, Caenorhabditis elegans, and Drosophila) are well-suited for the 
analysis of the molecular anti-aging mechanisms of CR due to their relative 
simplicity and shorter time needed to complete longevity studies, as 
discussed in more detail elsewhere (Fontana et al 2010 a, Kenyon 2005). 
However, the metabolic, anatomical, physiological and lifespan differences 
between these invertebrate model organisms and the mammalian systems are 
enormous. Rodents provide an extremely valuable and flexible animal model 
in which to determine the ability of CR to extend maximum lifespan and 
healthspan in a mammalian system. In rodents, a 30–60% reduction in 
calorie intake below usual ad libitum intake initiated early in life caused a 
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proportionate 30–60% increase in maximum life span (Weindruch and 
Walford 1988, Masoro 2005). CR started in adulthood (age 12 months) 
extended maximum life span by only 10–20% (Weindruch and Walford 
1982). To date, mice and rats are the only mammals in which CR has clearly 
been shown to increase both average and maximal lifespan, and to decelerate 
many age-dependent physiological and structural changes in multiple organs 
and tissues. In addition, data from studies with laboratory rodents found that 
CR without malnutrition increases healthspan by preventing or delaying the 
occurrence of a wide range of chronic diseases (Figure 1). 
 
Figure 1: Some of the physiological changes associated with calorie 
restriction in mammals. 
 In rodents, cancer is the leading cause of death, accounting for 70–80% of 
all deaths, and CR has been shown to inhibit spontaneous, chemically-
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induced and radiation-induced tumors in several murine models of cancer 
(Longo and Fontana 2010). CR without malnutrition has also been shown to 
prevent or delay the occurrence of chronic nephropathies and 
cardiomyopathies, the second leading causes of death in rodents (Weindruch 
and Walford 1988, Shimokawa et al 1993). Moreover, in ApoE knockout 
mice CR reduced the size and progression of atherosclerotic lesions when 
compared to ApoE-/- mice fed ad libitum, which developed more advanced 
and fibrotic lesions (Guo et al 2002). Diabetes, autoimmune and respiratory 
diseases are also prevented by CR (Weindruch and Walford 1988, Masoro 
2005). Finally, CR in mice decreases neurodegeneration, β-amyloid 
deposition in the brain and enhances neurogenesis in animal models of 
Alzheimer disease, Parkinson disease, Huntington disease, and stroke (Cohen 
et al 2009, Mattson 2005). However, under certain conditions chronic CR 
may also potentially impair some key functions, such as immunity and 
wound healing. For example, the healing of skin wounds is reduced in long-
term CR mice, but is greatly accelerated by a short period of ad libitum 
feeding before the wound is inflicted in CR animals (Reed et al 1996). In 
addition, accumulating data suggest that in mice housed in pathogen free 
facilities severe CR increases susceptibility to infections by bacteria, virus 
and worms, even though CR has been shown to delay the age-dependent 
decline in certain immune functions (Kristan 2008). Considering the breadth 
of organisms that respond positively to CR, should it be expected that non-
human primates would likewise show similar results? There are two active 
randomized, non-human primates studies testing the benefits of long-term 
CR on disease prevention and longevity in rhesus monkeys, one at the 
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University of Wisconsin at Madison and another at the National Institute on 
Aging (NIA) (Ingram et al 1990, Kemnitz et al 1993). Both trials have shown 
that long-term, moderate (~30%) CR can be safely initiated and maintained 
in a primate species. The recent results reported by the Wisconsin group are 
the first to show a significant CR-induced benefit in reducing age-related 
mortality and disease in rhesus monkeys (Colman et al 2009). However, 
when also deaths due to acute conditions (e.g., complications of anesthesia, 
gastric bloat, endometriosis, and injury) were included, overall mortality was 
not significantly different between the CR and control monkeys, even if the 
trend was still in the anticipated direction (P = 0.16). Although the 
demonstrated health and lifespan benefits are significant findings, a number 
of previous studies have suggested the plausibility of this outcome. Similar 
to rodents, CR in rhesus monkeys results in lower total and abdominal 
adiposity, improved insulin sensitivity and lipid/lipoprotein profile, 
decreased body temperature, decreased serum triiodothyronine concentration 
and reduced inflammation (Kemnitz 1994, Lane 1996, Roth 2002, Kim 
1997). However, as rhesus monkeys have a maximum life span of 40 years, 
it may be another 10 years before maximal life span data become available 
on these primates. 
1.1.2 Calorie Restriction in humans 
It is difficult to determine whether CR has beneficial effects on intrinsic 
aging and maximal lifespan in humans, because there are no validated 
biomarkers of aging and because it is impractical to conduct randomized 
diet-controlled, long-term survival studies in normal-weight humans. Data 
from epidemiological studies suggest that CR has beneficial effects on 
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human longevity. These studies include natural experiments, such as a study 
on the inhabitants of Okinawa (Japan) who were known to consume fewer 
calories than residents of the main Japanese islands (Willcox et al 2007). In 
this cohort of Okinawans (aged 65+) mortality from coronary heart disease 
and cancer was markedly lower than in the average mainland Japanese and 
US population (Kagawa 1978). Another category of studies in humans 
includes more controlled demonstrations of the effects of CR in normal-
weight individuals, such as occurred with Biosphere 2 which took place in a 
closed ecosystem in Arizona from 1991 to 1993, involved four men and four 
women who experienced a forced decrease in calorie intake for 18 months, 
because of an unanticipated decrease in food availability (Walford et al 
1992). This reduced energy intake resulted in a reduction of many 
anthropometric and physiological parameters, including reductions in body 
weight, blood pressure, fasting blood glucose, insulin, cholesterol, 
triiodothyronine and white blood cells (Walford et al 1992). 
Another series of metabolic and physiological studies have been conducted 
in members of the Calorie Restriction Society, which is a group that practices 
self-imposed CR in the belief that CR will extend their healthspan and 
lifespan. The CR group consists of lean volunteers, who had been eating 
about 1800 kcal/day for an average of 6.5 years, which is ~30% less calories 
than age-matched and sex-matched volunteers consuming a typical Western 
diet (WD) (Holloszy and Fontana 2007). The CR society members eat a diet 
rich in nutrient-dense foods, including a wide variety of vegetables, fruits, 
whole grains, nuts, egg whites, fish, low-fat dairy products and lean meat, 
which supplies more than 100% of the recommended daily intake (RDI) for 
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all essential nutrients. The decrease in energy intake resulted in a decrease in 
BMI from 23.7 kg/m2 at the beginning of CR to a currently steady BMI of 
19.6 kg/m2 (Holloszy and Fontana 2007); total body fat averaged 6.7% in the 
CR men and 22.4% in the comparison group men. The metabolic and 
physiological data from members of the calorie restriction society show that 
CR provides powerful protective effects against overweight/obesity, type 2 
diabetes, inflammation, and left ventricular diastolic dysfunction that are 
similar to those that occur in CR rodents and monkeys (Meyer et al 2006, 
Fontana et al 2004). Serum total cholesterol, low density lipoprotein 
cholesterol, triglycerides, fasting glucose, fasting insulin were all 
significantly lower, whereas HDL-C was higher, in the CR group than in the 
US diet control group (Fontana et al 2004). In particular, the CR society 
members appear to have much lower levels of blood pressure (both systolic 
and diastolic blood pressure) and inflammatory markers (i.e., C-reactive 
protein, tumor necrosis factor-α, and interleukin-6) than healthy, age- and 
sex-matched controls eating typical Western diets (Meyer et al 2006, Fontana 
et al 2004, Fontana et al 2010 b). 
Although research on CR in humans is still at an early stage, available 
information suggests that CR induces a number of the same adaptive 
response that occurs in laboratory animals. For example, CR results in some 
of the same hormonal adaptations related to longevity in CR rodents, 
including lower circulating concentrations of triiodothyronine, testosterone, 
and estradiol, and increased adiponectin and steroid hormone binding protein 
concentrations (Fontana et al 2010 b, Fontana et al 2006, Cangemi et al 
2010). However, key differences in the metabolic effects of CR exist 
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between mice and humans. In rodents, CR without protein restriction induces 
a 20–40% reduction in the level of insulin-like growth factor-1 (IGF-1), an 
important growth factor that mediates proliferation and inhibits apoptosis 
(Sonntag 1999). In contrast, in humans, severe CR does not reduce serum 
IGF-1 and IGF-1/IGFBP-3 concentrations, unless protein intake is also 
reduced (Fontana et al 2008). 
1.1.3 Metabolic and molecular mechanisms of Calorie restriction 
Since 1935, many mechanisms have been proposed as the biological basis of 
the life-prolonging and anti-aging actions of CR; none is strongly supported 
by available evidence, but it is entirely possible that the actions of CR 
involve a combination of metabolic, physiological and cellular adaptations to 
CR itself (McCay et al 1935, Brown-Borg 2007). It is well established that 
nutrient-sensing pathways are key modulators of the aging process; different 
nutrients can activate different pathways directly or indirectly (Fontana et al 
2010 a). For example in mice, CR down-regulates the insulin/IGF-1/mTOR 
pathways, which, in turn, activates other anti-aging pathways in various 
mammalian cells (Salmon et al 2005, Kennedy et al 2003) (Figure 2). 
Mutations that cause a down-regulation of the insulin/Igf-1/mTOR signaling 
pathways can substantially increase healthspan and lifespan in mice (Fontana 
et al 2010 a, Bartke 2005). For example, decreased IGF-1 signaling is 
involved in the delayed aging phenotype of IGF-1 receptor-deficient mice, 
klotho transgenic mice, and pregnancy-associated plasma protein A (PAPP-
A) knock-out mice (Holzenberger et al 2003, Kurosu et al 1998, Conover 
and Bale 2007). In contrast, mice overexpressing the GH receptor have very 
high concentrations of IGF-1, larger body size, shorter lifespan, and an 
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increased incidence of cancer, kidney and neurodegenerative disease (Bartke 
et al 2002). In addition to alteration in IGF-1 signaling, alterations of the 
insulin and mTOR pathways appear to contribute to the effect of CR on 
longevity. 
 
Figure 2: Calorie restriction (CR)-induced metabolic, molecular, and 
cellular adaptations. A chronic negative energy balance induced by dietary 
restriction triggers multiple metabolic adaptations including a reduction in 
circulating levels of growth factors (i.e., IGF-1), anabolic hormones (e.g., 
insulin, testosterone, estradiol, leptin), inflammatory cytokines (e.g., IL-6 
and TNF-alpha), and key hormones that regulate thermogenesis and cellular 
metabolism (e.g., triiodothyronine (T3), cathecolamines), and an increase in 
hormones that suppress inflammation (e.g., cortisol, ghrelin, and 
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adiponectin). Concomitantly, several key molecular adaptations take place, 
including a down-regulation of the insulin/IGF pathway (i.e., 
PI3K/Akt/mTOR), and an upregulation of two energy-sensing pathways (i.e., 
SIRT and AMPK which activates FOXO. The activation of FOXO in turn 
modifies several ‘longevity genes,’ including up-regulation of DNA repair 
genes (e.g., DDB1), autophagy genes (e.g., beclin), and a down-regulation of 
genes that control cell proliferation (e.g., cyclin D). DR induces also a 
down-regulation of inflammatory pathways (e.g., NFkB), and an up-
regulation of genes that enhance protection against molecular damage (e.g., 
Nrf2, HSP70). These DR-induced metabolic and molecular modifications are 
responsible for several important cellular adaptations, that antagonize the 
accumulation of macromolecular damage, abnormal cell proliferation, and 
cellular senescence. (Fontana et al 2014). 
 
Other important CR-mediated neuroendocrine adaptations, that have been 
hypothesized to play an important role in mediating the anti-aging effects of 
CR, are: (1) reduced levels of hormones that regulate thermogenesis and 
cellular metabolism (e.g., thyroid hormones, cathecolamines), (2) reduced 
levels of anabolic hormones (e.g., testosterone, estradiol, insulin, leptin), and 
(3) increased levels of hormones that suppress inflammation (e.g., 
glucocorticoids, adiponectin, ghrelin) (Fontana and Klein 2007) (Figure 2). 
Accretion of oxidative damage with time has been hypothesized to play a 
central role in the biology of aging and age-associated diseases (Harman 
theory of aging) (Sohal et al 2002). Oxidative damage to macromolecules 
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(i.e., DNA/RNA, proteins and lipids) in cells and tissues exponentially 
increases with aging. Long-term CR reduces the age-associated accumulation 
of oxidative damage to proteins, lipids and DNA (Sohal and Weindruch 
1996). This attenuation of the accumulation of oxidative damage can be due 
to either a decreased rate of generation of reactive oxygen molecules, or to 
increased efficiency of protective processes, or to an increase in repair 
activity, or to a combination of these processes (Figure 2). However, most of 
the evidence in support of the Harman theory of aging is just associative, and 
accumulating data do not support a key and independent role of oxidative 
stress in modulating aging in mammals (Muller et al 2007). 
1.2 Anorexia Nervosa 
Anorexia Nervosa (AN) is a complex multi-factorial disease in which 
genetic, biological and psychological factors, interacting each other, 
contribute significantly to susceptibility (Kaye et al 2009). AN primarily 
affects adolescent girls and young women; it is characterized by distorted 
body image and excessive dieting that leads to severe weight loss with a 
pathological fear of becoming fat. 
1.2.1 Definition of Anorexia Nervosa according to the DSM-V 
The American Psychiatric Association published the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) 2013, 
classifying anorexia nervosa as: 
	   20	  
• Persistent restriction of energy intake leading to significantly low 
body weight (in context of what is minimally expected for age, sex, 
developmental trajectory, and physical health). 
• Intense fear of gaining weight or becoming fat, even though 
underweight. 
• Disturbance in the perception of body weight or shape.  
Furthermore DSM-V allows us to specify two different types of anorexia 
nervosa:  
• Restricting Type: in which individuals limit food intake;  
• Binge-Eating / Purging Type: in which a person engages in binge 
eating followed by subsequent purging behavior (self-induced 
vomiting / laxative abuse). 
1.2.2 Prevalence and Incidence of Anorexia Nervosa 
The average prevalence rate for strictly defined AN young women is about 
0.3%, whereas the incidence of anorexia nervosa is 8 cases per 100,000 
population per year (Hoek et al 2003). Studies based on long study periods 
have revealed an upward trend in the incidence of anorexia nervosa since the 
1950s. The increase is most substantial among 15–24-year old females with 
an estimated rate of increase of 1.03 per 100,000 persons from 1935 to 1989 
(Hoek et al 2003).  
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1.2.3 Anorexia Nervosa and Immune System  
Extreme CR and low body fat stores in AN patients are associated with 
alterations of the immune system (Marcos et al 2003). In particular, AN 
patients frequently have leukopenia and relative lymphocytosis, but 
interestingly they seem to be protected against some infectious disease (e.g. 
common viral infections and other nosocomial infective disease) (Nova and 
Marcos 2006).  
Lymphocytes and natural killer (NK) cells play a central role in regulating 
the immune response against pathogens. Several adipokines (i.e. leptin and 
adiponectin) produced by the adipose tissue and some nutrients (e.g. 
vitamins and trace elements) play a key role in preserving the homeostasis of 
T-cells and NK cells (Muñoz and Costa 2013, Gostner et al 2013, Kowalska 
et al 2011, Gustafsson et al 2013, Caspar-Bauguil et al 2006, La Cava and 
Matarese 2004, Galgani et al 2010). However, little is known on the 
metabolic, molecular and functional adaptations induced by extreme and 
sustained CR in young AN patients on lymphocytes and NK cells. To the 
best of our knowledge, the only few studies conducted so far on lymphocyte 
populations in AN subjects were inconclusive, probably due to heterogeneity 
of the study subjects (Saito et al 2007, Pászthy et al 2007). 
 
1.3 First Aim of the study 
Calorie restriction without malnutrition is the most robust intervention to 
slow aging and extend healthy lifespan in experimental model organisms. 
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Several metabolic and molecular adaptations have been hypothesized to play 
a role in mediating the anti-­‐‑ aging effects of CR, including enhanced stress 
resistance, reduced oxidative stress and several neuroendocrine 
modifications. However, little is known about the independent effect of 
circulating factors in modulating key molecular pathways. The first aim of 
this study was to use sera collected from individuals practicing long-­‐‑ term 
CR and from age-­‐‑ and sex-­‐‑ matched individuals on a typical US diet to 
culture human primary fibroblasts and assess the effects on gene expression 
and stress resistance. These cellular and molecular adaptations could mirror 
some of the key effects of CR in animals. 
 
1.4 Second Aim of the study 
Anorexia nervosa is an excessive form of calorie restriction associated with 
pathological weight loss and alterations of the immune system. However, 
AN patients seem to be protected from common viral infections. The second 
aim of the present study was to investigate the metabolic, molecular and 
immunological adaptations induced by sustained extreme CR in the 
peripheral blood mononuclear cells (PBMCs) of patients with restrictive 
alimentary AN. 
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2. MATERIALS AND METHODS 
2.1 Human subjects 
Fifteen women who met DSM-V criteria for AN, twelwe individuals 
belonging to the Calorie Restriction society  who had been practicing severe 
CR with adequate nutrition for an average of 7 years (range 3-20 years) and 
33 normal weight controls  were enrolled in this study (American Psychiatric 
Association 2013). Control subjects were matched with the CR and AN 
groups in terms of age and sex. The characteristics of the study subjects are 
shown in Tables 1 and 2. No patient had been affected by infectious diseases 
or required medical treatment or hospitalization during the previous 5 years. 
All had undergone standard vaccination programs during childhood. None of 
their parents had experienced a major eating disorder. The research was 
performed according to the Helsinki II declaration and all enrolled subjects 
gave informed consent to the study. Height was measured without shoes to 
the nearest 0.1 cm. Body weight was obtained on a balance scale in the 
morning. Body mass index (BMI) was calculated by dividing body weight by 
the square of height (kg/m2). A venous blood sample was obtained from each 
participant the morning after a 12-hour fast and analyzed by routine assays 
for complete blood count as well as a comprehensive metabolic panel to 
assess current metabolic, kidney and liver function and electrolyte balance. 
Additional blood samples were stored at −80 °C, and later assayed in batch 
to measure levels of inflammatory and anti-inflammatory cytokines, 
adipokines and hormones. Specifically, soluble CD40L (sCD40L), soluble 
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intracellular adhesion molecule (sICAM-1), monocyte chemoattractant 
protein-1 (MCP-1), myeloperoxidase (MPO), resistin and soluble tumour 
necrosis factor receptor (sTNFR) were analyzed using the bead-based analyte 
detection system Human Obesity 9plex kit (Bender MedSystem Inc., 
Burlingame, CA) in duplicate serum samples. Leptin, adiponectin, IGF-1 and 
IGFBP-3 were measured with a highly sensitive ELISA kit (R&D Systems, 
Minneapolis, MN, USA) following the manufacturer’s protocol. Total 
catecholamines were determined by HPLC (Hewlett Packard 1100, BioRad, 
Herts, UK) in 24h urine. 
2.2 Human fibroblast cell culture 
The BJ human fibroblast cell line was obtained from ATCC and used in 
these experiments. BJ cells were cultured in 75 cm2 culture flasks containing 
basic culture medium: 86% of E-MEM medium supplemented with 10% 
fetal bovine serum (Sigma-Aldrich, St. Louis, MO, USA), 1% Sodium 
Pyruvate, 1% non-essential amino acids, 1% GlutaMAX and 1% antibiotics 
(GIBCO, Carlsbad, CA, USA) until the time of treatment. Cells were 
cultured in a humidified incubator at 37°C and 5% CO2. For the experiments, 
FBS was replaced with human serum from CR, AN and control participants. 
Both FBS and human serum were heat inactivated for 30 minutes at 55°C. 
2.3 Microarray analysis 
BJ cells were seeded at a concentration of 4.000 cells/cm2 in 25 T-25 flasks; 
when they reached 60% of confluence, the cells were starved for 24h without 
FBS. After starvation, 10% of human serum from 12 CR and 13 control 
individuals was added to the cultures for 48h. Whole cells were detached 
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from the flask with trypsin/EDTA (Sigma-Aldrich, St. Louis, MO, USA) and 
Total RNA was extracted using the mirVANA (Ambion, Inc, Austin, TX, 
USA) according to manufacturer’s protocol. Integrity of total RNA was 
evaluated using capillary electrophoresis (Bioanalyzer 2100, Agilent 
technologies, Santa Clara, CA, USA) and quantified using a Nanodrop 1000 
(Nanodrop, Wilmington, DE). Aliquots of RNA (400 ng) samples were 
amplified according to the specifications of the Illumina® TotalPrep™ RNA 
Amplification Kit (Ambion, Austin, TX, USA) to produce a pool of biotin-
labeled RNA corresponding to the polyadenylated (mRNA) fraction. The 
cRNA samples were applied to the arrays of Illumina whole-genome 
HumanHT-12 v 4.0 (Illumina, San Diego, CA, USA) and hybridized 
according to the manufacturer’s specification. Each array on the BeadChip 
targets over 25.000 annotated genes using 3-micron beads bearing covalently 
attached 50-base oligonucleotide probes. Each probe interrogates a single 
gene, and each bead type is represented with an average 15-fold redundancy 
on every array. The BeadChips were scanned with the Illumina's Beadarray 
system scanner (Illumina, San Diego, CA, USA). The hybridization images 
signal intensity was extracted and background subtracted using Illumina Inc. 
BeadStudio software version 3.3.7. The produced data were checked for the 
Illumina internal quality control and loaded into Bioconductor software 
(Gentleman et al 2004, Ritchie et al 2006) for statistical analysis using lumi 
package (Du et al 2008) (see below). The data discussed in this thesis have 
been deposited in NCBI's Gene Expression Omnibus (Edgar et al 2002) and 
are accessible through GEO Series accession number GSE41790. 
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(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=nnonbsicqouiilw&ac
c=GSE41790). 
2.4 Real Time PCR 
Real-time PCR was used to verify microarray data and to evaluate the 
antioxidant status in PBMCs from AN patients and BJ cells cultured with 
sera from AN and control subjects. Total RNA was DNase I treated and 
reverse transcribed using the High Capacity RNA-to-cDNA kit (Applied 
Biosystems, Carlsbad, CA, USA). The cDNA was then used to evaluate the 
relative expression of selected genes from the microarray results including 
SOD2, GPX1, IDH2, GSTK1 and GSTT1 using specific TaqMan Gene 
Expression Assays (Applied Biosystems, Carlsbad, CA, USA), which are 
pre-designed and pre-optimized gene-specific probe sets. To evaluate the 
antioxidant status in PBMCs from AN patients and BJ cells cultured with 
sera from AN and control subjects 2.9 µg of reverse transcribed RNA were 
added to 540 µL of TaqMan Fast Universal PCR Master Mix (Applied 
Biosystems), and dispensed 10 µL per well into a TaqMan Human 
Antioxidant Mechanisms 96-well Fast Plate (Applied Biosystems) that 
evaluates 92 antioxidant-associated genes and 4 endogenous control genes. 
DNA was amplified using the Applied Biosystems 7900 Fast Real-Time 
PCR system according to the manufacturer’s protocol. The relative amount 
was calculated from the threshold cycles with the instrument's software (SDS 
2.0, Applied Biosystems, Carlsbad, CA, USA), according to the 
manufacturer's instructions. We used the comparative cycle threshold (Ct) 
method (2 - ΔΔCT) to calculate relative gene expression under experimental 
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and control conditions normalized to GAPDH. The results are expressed 
either as the abundance of the gene of interest relative to the house keeping 
gene (2 - ΔCT), or as fold change over control values (2 - ΔΔCT). 
2.5 Differential stress resistance assays in response to hydrogen peroxide 
To determine the differential stress resistance to hydrogen peroxide of serum 
from CR, AN and control individuals, BJ cells were seeded in 96-well plates 
at a concentration of 3000 cells/well in 86% D-MEM low glucose without 
phenol red  supplemented with 1% sodium pyruvate, 1% non-essential amino 
acids, 1% GlutaMAX  and 1% antibiotics (GIBCO, Carlsbad, CA, USA). 
After cells had seeded, media were removed and replaced with media 
containing 10% of human serum from 11 CR, 10 AN or from 10 control 
individuals for 48h. Each assay was performed in triplicate. After incubation, 
freshly prepared hydrogen peroxide was added to the plates at concentrations 
of 200, 400, 600, 800 and 1000 µM, and cells were challenged for 24h. Cell 
viability was determined by the addition of 20 µl of the ready-to-use WST1 
reagent (Roche diagnostics, Mannheim, Germany) to each well; the cells 
were incubated for 3h at 37°C and 5% CO2 in a humidified incubator. The 
absorbance of the formazan dye formed was measured at a wavelength of 
450 nm using a microplate spectrometer. The measured absorbance directly 
correlated to the number of viable cells. 
2.6 Immunophenotyping 
Immunophenotyping was performed on a whole blood sample from 10 AN 
and 10 controls with an EPICS XL flow cytometer (Beckman Coulter, Milan, 
Italy) using the Beckman Coulter XL System II software program. Cell 
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populations were identified using triple combinations of human monoclonal 
antibodies, namely, fluorescein isothiocyanate [FITC]- and phycoerythrin 
[PE]-anti-CD3, PE- and PC-5-anti-CD4, PC5-anti-CD8, PE-anti-CD16, PC5-
anti-CD19, PE-anti-CD25, FITC-anti-CD45, and PE-anti-CD56, all from 
Coulter Immunotech (Marseille, France). 
2.7 Cell cultures, proliferation assays and cytokine measurement 
Human peripheral blood mononuclear cells (PBMCs) were isolated from AN 
patients and controls by stratifying 15 mL of whole blood on 5 mL of Ficoll-
Paque PREMIUM (GE Healthcare) and centrifuging the solution at 1.2×g for 
20 min. PBMCs (2×105 per well) were cultured, in triplicate, in 96-well 
round-bottomed plates, in medium supplemented with 5% (vol/vol) 
autologous (AS) subject serum or 5% (vol/vol) heterologous (HS) 
commercial human serum (Sigma-Aldrich, St. Louis, MO, USA) and were 
stimulated or not in parallel with 0.1 µg/mL anti-CD3 mAb (OKT3) 
(Orthoclone, Janssen-Cilag, Cologno Monzese, Italy). Stimulated PBMCs 
were maintained in culture for 48h, and H3 thymidine (Amersham-
Pharmacia Biotech, Cologno Monzese, Italy) was added (0.5 µCi per well) 
during the last 12h. Cells were harvested on fiberglass filters using a 96-well 
cell harvester (Tomtec Inc., Hamden, CT, USA) and were counted in a 
Betaplate liquid scintillation counter (Wallac, Gaithersburg, MD). 
Supernatants were collected from 48h TCR-stimulated T cells from AN 
patients and control subjects, and stored at -80°C before analysis. The human 
Th1/Th2/Th9/Th17/Th22 13plex kit FlowCytomix (Bender Medsystems 
GmbH, Vienna, Austria) was used to detect human TNFα, IFNγ, IL-1β, IL-
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2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12p70, IL-13, IL-17α, IL-22 by flow 
cytometry (Becton-Dickinson, San Diego, CA) according to the 
manufacturer’s instructions. 
2.8 Bioenergetics and metabolism of T lymphocytes 
The mitochondrial respiratory rate was measured in PBMCs from a random 
subset of AN (n=4) and control (n=3) subjects, in basal condition and upon 
TCR-mediated stimulation (anti-CD3). Real-time measurements of the 
extracellular acidification rate (ECAR) and of the oxygen consumption rate 
(OCR) were made using an XF-96 Extracellular Flux Analyzer (Seahorse 
Bioscience, North Billerica, MA, USA). Cells were cultured (2x105 
cells/well in XF-96-well culture plate) in triplicate in 100 µl DMEM 
complete medium, leaving the temperature control wells empty, and 
incubated at 37°C for 12h. ECAR was measured in XF media in basal 
condition and in response to 10 mM glucose (basal glycolysis), 5 µM 
oligomycin (maximal glycolysis) and 100 mM 2-DG (glycolytic capacity). 
OCR was measured in XF media (non-buffered DMEM medium, containing 
10 mM glucose, 2 mM L-glutamin, and 1 mM sodium pyruvate), under basal 
conditions (basal respiration) and in response to 5 µM oligomycin (ATP-
linked respiration), 1.5 µM of carbonylcyanide-4-(trifluoromethoxy)-
phenylhydrazone (FCCP) and 1 µM antimycin and rotenone (maximal 
respiration) (Sigma Aldrich).  
2.9 Statistical analysis 
Microarray data produced were quality checked with arrayQualityMetrics 
(Ritchie et al 2006) package under R version 2.15.1 Bioconductor software 
	   30	  
(Gentleman et al 2004) and undetectable and low detection value probes 
were filtered out from further analysis accordingly to the lumi package 
standards (Du et al 2008). To identify differentially expressed genes, based 
on a moderate t-test, the Limma package (Wettenhall et al 2006) was used 
and genes were selected based on a p-value cut-off <0.05 (after FDR 
adjustment) and absolute fold change >1 following the Macroarrays Quality 
Control Program criteria (Shi et al 2006). IPA software was then used 
(www.ingenuity.com) to detect the enrichment of biofunctions and networks 
in the resulting list. Core analysis was performed using the following 
settings: Reference set: HumanHT-12 v 4.0; Relationship to include: Direct 
and Indirect; Includes Endogenous Chemicals; Filter Summary: Consider 
only molecules and/or relationships where (species = Uncategorized (e.g. 
chemicals) OR Human) AND (confidence = Experimentally Observed). 
Canonical pathways analysis has been performed using as scoring method 
BH Multiple Testing Correction p-values set to a threshold value of 0.05. 
Meta-analysis was performed using the CAMERA function implemented in 
the Bioconductor Limma package for a 'competitive gene set test' (Wu and 
Smyth 2012). The resulting top Molecular signatures have been further 
analyzed using a ‘focused’ gene set test ROAST (Wu et al 2010). All the list 
of genes organized as Signature and present in The Molecular Signature 
Database C2 collection (MSigDB) (www.broadinstitute.org/gsea/msigdb/) 
were updated to official symbols using the illumina annotation file 
HumanHT-12_V3_0_R2_11283641_A. Representation of differentially 
expressed genes in their Genomic localization and visual representation of 
their relationships with the different pathways were produced using CIRCOS 
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software (Krzywinski et al 2009). The Mann Whitney U test was used to 
compare group variables in all the other tests. Statistical significance was set 
at P<0.05. All data were analyzed by using the PASW package for Windows 
(v18; SPSS Inc Headquarters Chicago IL, USA) and Graphpad InStat3 
version 4.0. 
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3. RESULTS 
Table 1 and 2 provide demographic, anthropometric and biochemical 
characteristics of the enrolled subjects. Mean values for body weight and 
BMI were significantly different between the selected groups. Total body 
weight and BMI were significantly lower in the CR and AN group than in 
the Control group (Table 1 and 2).  
Table 1: Characteristics of the calorie restricted (CR) and subjects 
eating Western Diets (WD) 
 CR group 
(n=12) 
WD group 
(n=13) 
P value 
Age (yrs) 57.8±8.4 55.7±8.7 ns 
Sex (M/F) 10/2 11/2  
Height (m) 1.73±0.07 1.76±0.12 ns 
Weight (Kg) 57.1±6.6 79.8±14.0 0.0002 
BMI (kg/m2) 19.1±1.2 25.7±2.3 P<0.0001 
Total body fat 
(%) 
9.8±4.8 25.9±5.6 P<0.0001 
Values are means ± SD 
Plasma glucose, insulin, leptin, IGF-1, prolactin, DHEA-s, and sTNFR1 
concentrations in the AN group were significantly lower than the CTR group 
(Table 2). However, serum concentrations of adiponectin, sCD40L, sICAM-
1, LDH, ALP and liver enzymes (i.e. ALT, GGT) were significantly higher 
in the AN group than in the CTR group (Table 2 and 3). Serum MPO and 
resistin levels were higher in the AN group than in CTR, but the difference 
was not significant (Table 2). Both the leptin/adiponectin (L/A) and the IGF-
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1/IGFBP-3 ratio were significantly lower in the AN than in the control group 
(Table 2). Despite undernutrition, AN patients did not show selective 
malnutrition in terms of vitamins and minerals (Table 3). 
 
Table 2: Main clinical and biochemical characteristics of the enrolled 
Anorectic (AN) and control (CTR) subjects 
 AN (n=15) CTR (n=20) 
P value 
 Mean SEM Mean SEM 
Age (yrs) 19.70 0.97 22.57 0.83 ns 
Height (m) 1.65 1.2 1.66 2.0 ns 
Weight (Kg) 43.3 1.2 56.6 2.6 <0.001 
BMI (kg/m2) 15.95 0.40 20.40 0.70 <0.001 
Glucose (mmol/L) 3.76 0.11 4.43 0.12 <0.001 
Total cholesterol 
(mmol/L) 
4.44 0.14 4.41 0.24 ns 
HDL-c (mmol/L) 1.66 0.12 1.86 0.14 ns 
Leptin (ng/mL) 1.00 0.34 15.08 1.88 <0.001 
Adiponectin (µg/mL) 16.43 1.51 11.09 1.41 0.02 
Leptin/adiponectin ratio 0.06 0.01 1.60 0.28 <0.001 
Insulin (µU/mL) 1.03 0.04 9.05 1.57 <0.001 
IGF-1 (ng/mL) 158.8 13.41 191.6 11.13 0.03 
IGFBP-3 (µg/mL) 3.33 0.18 2.99 0.15 ns 
IGF-1/IGFBP-3 ratio 47.94 3.32 64.90 3.69 0.004 
DHEA-s (µg/dL) 87.20 9.17 218.50 34.97 <0.001 
Prolactin (ng/mL) 5.95 0.71 19.84 3.29 <0.001 
sTNFR1 (ng/mL) 1.14 0.06 1.45 0.12 0.04 
sCD40L (ng/mL) 865.6 102.8 608.2 108.8 0.04 
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sICAM-1 (ng/mL) 430.5 75.50 302.9 20.52 0.04 
MPO (ng/mL) 268.7 28.98 216.50 25.00 ns 
MCP-1 (ng/mL) 377.0 39.67 365.3 35.32 ns 
Resistin (µg/mL) 9.51 1.60 7.54 0.67 ns 
Catecholamines (µg/24h) 24.56 3.80 76.80 9.04 <0.001 
 
DHEA-s: Dehydroepiandrosterone-sulphate; IGFBP-3: IGF-1 binding 
protein 3;  MCP-1: monocyte chemotactic protein 1; MPO: 
myeloperoxidase; sCD40L: soluble CD40 ligand; sICAM-1: soluble 
intracellular adhesion molecule; sTNFR1: soluble tumor necrosis factor 
receptor 1. All biochemical parameters were measured in serum	   except 
catecholamines in 24h urine sample. *p value at Mann Whitney U test. 
Table 3: Main biochemical characteristics of the enrolled AN and 
control subjects 
 AN (n=15) CTR (n=20) 
P value 
 Mean SEM Mean SEM 
Na+ (mg/dL) 141.40 0.76 141.64 0.79 ns 
K+ (mg/dL) 4.32 0.14 4.47 0.07 ns 
Ca++ (mg/dL) 9.72 0.08 9.63 0.08 ns 
Phosphorus (mg/dL) 3.86 0.04 3.77 0.18 ns 
Iron (mg/dL) 85.50 6.34 84.00 9.74 ns 
Total Protein (g/dL) 7.45 0.11 7.34 0.14 ns 
Albumin (g/dL) 5.02 0.09 4.84 0.07 ns 
Triglycerides 
(mmol/L) 
0.79 0.09 0.55 0.04 0.03 
AST (U/L) 30.10 4.64 19.09 2.96 ns 
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A
A
L
T
: alanine aminotransferase; ALP: alkaline phosphatase; AMS: amylase; 
AST: aspartate aminotransferase; CHE: cholinesterase; CK: creatine 
kinase; FSH: follicle-stimulating hormone; GGT: γ-glutamyl transferase; 
HB: hemoglobin; HCT: hematocrit; LDH: lactate dehydrogenase; LH: 
luteinizing hormone; MCV: mean cell volume; RBC: red blood cells; TSH: 
ALT (U/L) 49.00 10.90 19.82 7.75 0.04 
GGT (U/L) 25.20 6.00 11.67 0.89 0.05 
ALP (U/L) 60.10 2.61 49.50 1.51 0.01 
CHE (U/L) 6336.43 826.84 7952.83 486.64 ns 
CK (U/L) 59.50 6.90 81.25 7.03 ns 
AMS (U/L) 82.67 8.81 74.11 8.58 ns 
LDH (U/L) 387.40 21.63 301.83 13.83 0.01 
Uric acid (mmol/L) 0.21 0.01 0.23 0.01 ns 
Urea (mmol/L) 4.98 0.50 4.71 0.25 ns 
Creatinine (mmol/L) 70.72 3.23 66.70 4.21 ns 
RBC (x106/mL) 4.35 0.13 4.39 0.08 ns 
HB (g/dL) 12.91 0.26 12.84 0.20 ns 
HCT (%) 39.43 1.03 37.86 0.45 ns 
MCV (fl) 90.57 1.45 86.45 1.17 0.04 
Estradiol  (pg/mL) 76.67 37.74 153.25 36.19 ns 
Progesterone (ng/mL) 2.26 1.41 5.17 1.62 ns 
LH (mU/mL) 3.23 1.22 4.69 0.77 ns 
FSH (mU/mL) 5.22 0.98 5.36 0.65 ns 
TSH (µU/mL) 2.44 0.45 1.76 0.22 ns 
FT3 (pg/mL) 2.59 0.17 2.69 0.07 ns 
FT4 (ng/dL) 1.04 0.07 1.05 0.03 ns 
Vitamin B12 (pg/mL) 608.75 93.39 413.10 35.66 ns 
Folate (ng/mL) 6.73 1.26 5.78 0.96 ns 
Vitamin A (µg/dL) 43.34 4.63 48.05 4.24 ns 
Vitamin E (µg/dL) 1260.03 81.63 1217.86 60.29 ns 
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thyrotropin; FT4: free thyroxine; FT3: free 3,5,3’-triiodothyronine. All 
biochemical parameters were measured in serum. *p value at Mann Whitney 
U test. 
3.1 Gene expression analysis shows up-regulation of genes involved in 
NRF2-mediated oxidative stress response in fibroblasts cultured with 
CR serum 
Mammalian fibroblasts have been extensively used to assess global 
transcriptional changes induced by circulating factors (i.e. serum) on cell 
function (Iyer et al 1999). To test the hypothesis that the CR-induced 
changes in circulating factors can influence cell function, we compared the 
transcriptional profiles of human primary fibroblasts treated with CR or WD 
serum. Differentially expressed genes were selected using a moderate t-test 
approach (Wettenhall et al 2006) and multiple test correction (Shi et al 
2006), and these genes were used to identify transcriptionally altered 
pathways. Ingenuity Pathways Analysis software (IPA) showed a significant 
association of a subgroup of 83 genes with many oxidative response-related 
pathways (Figure 3). 
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Figure 3: Pathway‐based analysis. Circos diagram shows the relationship 
between CR differentially expressed genes and oxidative‐related pathways. 
Ribbon ends represent links between genes and pathways while the width of 
the ribbon correlates with the number of genes involved. Segments in the 
outer ring indicate the total number of genes involved in the corresponding 
pathways while thin internal segments indicate the number of up‐regulated 
(light green) and down‐regulated (orange) genes. 
  
In particular, NF-E2-related factor 2 (Nrf2)-mediated oxidative stress 
response contained 30 genes that were dysregulated in the treated fibroblasts 
(BH p-value 3.33E-02), and many of them were direct expression effectors of 
Nrf2 activity (Figure 4). Meta-analysis performed using a competitive gene 
set test (Wu and Smyth 2012) pinpoints 11 molecular signatures significantly 
downregulated in a ‘self-contained’ gene test (Table 4 red Highlights). 
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Figure 4: Connectivity map of NRF2‐mediated oxidative stress response 
adapted from IPA software. Pathways analysis identified the NRF2‐mediated 
oxidative stress response pathway with a statistically significant value (BH 
p‐value 3.33E‐02). Green colored shapes represent up‐regulated genes while 
red ones represent down‐regulated genes of fibroblast cell lines treated 48 
hours with CR serum. 
  
Table 4: Gene Set Enrichment CAMERA and ROAST results 
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To further investigate the result of microarray data and confirm the 
association with oxidative response-related pathways, we performed 
quantitative real-time PCR for the following genes which were shown by 
microarray to be detectable and significantly dysregulated: GSTK1, GPX1, 
SOD2, GSTT1, and IDH2. As shown in Figure 5, relative abundance of 
message for these genes was significantly higher in the CR group than the 
control group (p<0.0005) with a fold change difference ≥ 2.2-fold. 
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Figure 5: Real Time qPCR analysis of GSTK1, GSTT1, IDH2, GPX1 and 
SOD2 expression in BJ cells cultured 48hs with CR and WD sera. (A‐E) 
Data are expressed as the gene of interest abundance relative to the GAPDH 
(Mean ± SEM); n = 12 CR, n = 13 WD. Student’s t test was used to 
determine P‐values. (F) Data are expressed as fold changes relative to CR 
cultures. 
3.2 Incubation with human CR serum increases stress resistance to 
hydrogen peroxide in vitro 
To confirm the gene expression findings with a functional test, human 
primary fibroblasts cultured for 48 hours with CR or WD sera were exposed 
to increasing concentrations of the powerful oxidizing agent, hydrogen 
peroxide (H2O2) for 24 hours. As shown in Figure 6, treatment with H2O2 
produced a dose-dependent decline in survival, but fibroblasts cultured with 
CR serum were significantly protected from the cytotoxic effect of the 
oxidant. 
 Figure 6: Differential Stress Resistance to hydrogen peroxide. A human 
fibroblast cell line (BJ) was cultured 48‐hrs with sera from CR and WD 
individuals. Cell viability (WST1 assay) was determined after a 24 h 
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treatment with H2O2 (0 – 1000 µM). Data are represented as means ± SEM. 
P‐ values were determined with 2way ANOVA with Bonferroni post test. 
***P < 0.001; **P < 0.01. 
 
At 600 µM about 67% of cells pretreated with CR serum were viable, while 
only 37% of cells pretreated with WD serum survived (p< 0.001), and even 
at higher H2O2 concentrations (800 µM) 32% of the cells pretreated with CR 
serum survived, while only 10% of the cells exposed to WD serum were still 
alive (p< 0.01). 
3.3 Immunophenotyping of AN patients and controls 
As shown in Table 5, AN patients had significantly fewer total leucocytes 
(p=0.033), lymphocytes (p=0.009), CD3+ cells (p=0.040), and NK (CD3-
CD16+CD56+) cells (p=0.033) than controls. Furthermore, AN patients had 
significantly fewer CD3+ T cells with a naive phenotype (CD3+CD45+RA+) 
(p=0.022); the same, albeit not significant, trend was observed for total 
CD4+ T cells and CD4+ T cells with a naive phenotype (CD4+CD45+RA+) 
(p=0.068). The absolute number of circulating CD4+CD28+, CD8+CD11b+ 
and CD3+CD16+CD56+ T cells was also significantly lower in AN patients 
(p=0.012, p=0.015, p=0.012 respectively). 
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Table	  5:	  Immunophenotype	  of	  AN	  and	  CTR	  subjects	  
	  
Cell	  type	  
AN	  (n=10)	  
Cells/mm3	  
(%)	  
CTR	  (n=10)	  
Cells/mm3	  
(%)	  
p	  value	  
Leucocytes	   3712.67±1132.88	   5642.73±1957.73	   0.033	  
Lymphocytes	   1596.89	  ±	  445.23	  (44.12	  ±	  8.53)	   2068.64	  ±	  475.65	  (39.29	  ±	  10.77)	   0.009	  
CD3+	   1196.11	  ±	  320.40	  (75.22	  ±	  4.10)	   1502	  ±	  341.60	  (72.91	  ±	  5.58)	   0.040	  
CD4+	   666.33	  ±	  120.13	  (43.11	  ±	  6.61)	   847.55	  ±	  197.60	  (41.36	  ±	  6.19)	   ns	  
CD8+	   426.56	  ±	  194.29	  (25.89	  ±	  4.41)	   533.18	  ±	  147.76	  (25.82	  ±	  4.77)	   ns	  	  
CD3-­‐CD16+CD56+	   123.22	  ±	  83.97	  (7.67	  ±	  5.12)	   268.82	  ±	  162.89	  (12.63	  ±	  6.13)	   0.033	  
CD19+	   251.00	  ±	  125.73	  (15.33	  ±	  4.55)	   259.09	  ±	  104.54	  (12.27	  ±	  3.93)	   ns	  
CD3+CD45+RA+	   593.06	  ±	  171.16	  (37.78	  ±	  7.24)	   815.24	  ±	  198.81	  (39.91	  ±	  6.61)	   0.022	  
CD3+CD45+RO+	   603.16	  ±	  250.39	  (37.44	  ±	  8.25)	   686.85	  ±	  196.52	  (33.00	  ±	  5.92)	   ns	  
CD4+CD45+RA+	   310.03	  ±	  64.08	  (20.78	  ±	  6.30)	   428.80	  ±	  166.87	  (21.09	  ±	  7.53)	   ns	  
CD4+CD45+RO+	   356.30	  ±	  121.55	  (22.33	  ±	  4.82)	   418.75	  ±	  	  140.84	  (20.27	  ±	  5.08)	   ns	  
CD8+CD45+RA+	   283.02	  ±	  169.30	  (17.00	  ±	  7.87)	   386.44	  ±	  121.03	  (18.82	  ±	  4.89)	   ns	  CD8+CD45+RO+	   143.53	  ±	  144.74	   146.74	  ±	  69.88	   ns	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(15.11	  ±	  8.71)	   (12.73	  ±	  4.38)	  
CD4+CD28+	   601.83	  ±	  113.86	  (38.89	  ±	  6.26)	   766.90	  ±	  168.33	  (37.64	  ±	  6.31)	   0.012	  
CD4+CD25+	   15.75	  ±	  9.60	  (1.00	  ±	  0.47)	   22.31	  ±	  6.14	  (1.09	  ±	  0.30)	   ns	  
CD4+CD8+	   15.27	  ±	  11.69	  (0.89	  ±	  0.57)	   34.07	  ±	  44.52	  (1.55	  ±	  1.57)	   ns	  
CD4+DR+	   17.31	  ±	  9.89	  (1.11	  ±	  0.57)	   19.75	  ±	  8.82	  (1.00	  ±	  0.45)	   ns	  
CD8+DR+	   23.00	  ±	  10.77	  (1.44	  ±	  0.50)	   25.47	  ±	  15.95	  (1.36	  ±	  1.12)	   ns	  
CD8+CD11b+	   41.93	  ±	  37.89	  (2.44	  ±	  1.57)	   117.58	  ±	  95.55	  (5.45	  ±	  3.62)	   0.015	  
CD3+CD16+CD56+	   29.11	  ±	  24.81	  (1.67	  ±	  1.05)	   119.91	  ±	  176.83	  (5.27	  ±	  6.28)	   0.012	  
CD3-­‐CD8+	   71.11	  ±	  50.04	  (4.22	  ±	  2.39)	   118.94	  ±	  94.33	  (5.55	  ±	  3.93)	   ns	  
CD4+/CD8+	  (ratio)	   26.31	  ±	  6.52	  (1.74	  ±	  0.51)	   34.55	  ±	  11.70	  (1.70	  ±	  1.66)	   ns	  	  
3.4 T-cell proliferative response and cytokine profiling in supernatants 
of isolated T cells 
We next evaluated the PBMC proliferative profile in AN and control subjects 
in medium supplemented with 5% pooled HS or 5% AS after stimulation 
with anti CD3 (OKT3 mAb). T-cell proliferation did not differ between AN 
patients and controls in either PBMC cultured with AS or HS serum (Figure 
7A and 7B). The cytokine profile evaluated in the supernatant of TCR-
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stimulated PBMCs (Figure 7C-O) revealed significantly higher IL-6 levels in 
AN than in control supernatants from cells cultured in HS medium (p<0.01) 
(Figure 7G). Interestingly, this effect was abolished when AN cells were 
cultured in AS medium (Figure 7G). TNFα levels were significantly 
decreased in stimulated-AS cultured AN and control cells compared with HS 
cultured cells (p<0.01). Similarly, IL-1β levels were decreased in supernatant 
from AS-cultured AN cells versus HS cultured AN cells (p<0.01). Treatment 
with AS resulted in a reduction of all the other tested inflammatory cytokines 
in anti CD3-stimulated AN cells compared with HS AN cultured cells 
although the trend was not statistically significant. 
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Figure 7: TCR-mediated PBMC proliferation in heterologous (HS) or 
autologous (AS) serum (A, B) and cytokine secretion (C-O) in supernatants 
from 48h anti-CD3 (OKT3 mAb) stimulated PBMCs from AN (n=10) and 
CTR subjects (n=10). Data are expressed as mean ± SEM and statistical 
analysis was performed with the  Mann Whitney non parametric U test. (** 
p≤0.01, *p<0.05). 
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3.5 Impaired glycolysis and mitochondrial respiration in T cells from 
AN patients 
To elucidate the impact of chronic caloric deprivation on the metabolic 
profile of immune cells we measured the ECAR and OCR, which are 
indicators of glycolysis and mitochondrial respiration, respectively, in 
PBMCs from AN and control subjects in unstimulated conditions (Figure 8) 
and upon TCR-mediated stimulation (anti-CD3) (Figure 9). After TCR-
mediated stimulation, activation of the glycolytic pathway was impaired in 
AN patients (Figure 9A), as testified by the reduced basal glycolysis 
(p=0.0126) (Figure 9B) and maximal glycolysis (p=0.0071) (Figure 9C), and 
also in terms of glycolytic capacity (p=0.0031) (Figure 9D). The same trend 
was observed in unstimulated cells (Figure 8A), but it was not significant 
(Figure 8B-D). Oxidative phosphorylation was also lower in PBMCs from 
AN patients (Figure 9E and Figure 8E) than in controls, as indicated by the 
decreased basal OCR in both unstimulated cells (Figure 8F) (p<0.0001) and 
anti-CD3 stimulated cells (Figure 9F) (p<0001). The same result was 
obtained after the addition of oligomycin (an ATP synthase inhibitor). 
Indeed, the amount of basal OCR required for ATP production, calculated as 
the difference between basal and oligomycin-induced OCR (“ATP-coupled 
respiration”), was significantly reduced only in AN after TCR-mediated 
stimulation (p=0.0173) (Figure 9G and Figure 8G). Finally, as expected, the 
addition of the mitochondrial uncoupler (FCCP) resulted in a dramatic 
increase in the OCR thereby showing that mitochondria had maximal 
respiratory capacity. Interestingly, OCR did not differ significantly between 
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AN and control subjects in either unstimulated or TCR-stimulated cells 
(Figure 8H and Figure 9H). 
 
Figure 8: Impaired glycolysis and mitochondrial respiration in unstimulated 
PBMCs from AN subjects. (A) Extracellular acidification rate (ECAR) 
bioenergetic profile. ECAR was measured in real time under basal 
conditions and in response to glucose, oligomycin and 2-Deoxy-D-glucose 
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(2DG) in unstimulated PBMCs from AN and CTR subjects. Indices of 
glycolytic pathway activation, calculated from the PBMCs bioenergetic 
profiles: (B) Basal (after the addition of glucose), (C) maximal (after the 
addition of oligomycin), and (D) glycolytic capacity (calculated as the 
difference of oligomycin rate and 2-DG rate) ECAR in AN and CTR. (E) 
Oxygen consumption rate (OCR) bioenergetic profile in unstimulated 
PBMCs from AN and CTR subjects. OCR was measured in real time under 
basal conditions and in response to  indicated mitochondrial inhibitors: 
oligomycin, carbonylcyanide-4- (trifluoromethoxy) -phenylhydrazone 
(FCCP), Antimycin A and Rotenone (Ant+Rot), using an XF-96 
Extracellular Flux Analyzer. Indices of mitochondrial respiratory function 
calculated from the AN and CTR anti-CD3 stimulated PBMC bioenergetic 
profiles: (F) Basal (before addition of oligomycin), (G) ATP-linked 
(calculated as the difference of basal rate and oligomycin rate) and (H) 
maximal (calculated as the difference of FCCP rate and Ant+Rot rate) OCR 
in AN and CTR. Cumulative data from 4 AN patients and 3 CTR subjects 
expressed as mean ± SEM, statistical analysis by Mann Whitney test. 
(**p≤0.01; ns=not significant). 
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Figure 9: Impaired glycolysis and mitochondrial respiration in AN PBMCs 
after TCR-mediated stimulation. (A) Extracellular acidification rate (ECAR) 
bioenergetic profile. ECAR was measured in real time under basal 
conditions and in response to glucose, oligomycin and 2-Deoxy-D-glucose 
(2DG) in anti-CD3-stimulated PBMCs from AN and CTR subjects. Indices of 
the glycolytic pathway activation, calculated from the PBMC bioenergetic 
profiles: (B) Basal (after the addition of glucose), (C) maximal (after the 
addition of oligomycin), and (D) glycolytic capacity (calculated as the 
difference of oligomycin rate and 2DG rate) ECAR in AN and CTR. (E) 
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Oxygen consumption rate (OCR) bioenergetic profile in anti-CD3-stimulated 
PBMCs from AN and CTR subjects. OCR was measured in real time under 
basal conditions and in response to  indicated mitochondrial inhibitors: 
oligomycin, carbonylcyanide-4- (trifluoromethoxy) -phenylhydrazone 
(FCCP), Antimycin A and Rotenone (Ant+Rot), using an XF-96 
Extracellular Flux Analyzer. Indices of mitochondrial respiratory function, 
calculated from PBMC bioenergetic profiles: (F) Basal (before addition of 
oligomycin), (G) ATP-linked (calculated as the difference of basal rate and 
oligomycin rate) and (H) maximal (calculated as the difference of FCCP rate 
and Ant+Rot rate) OCR in AN and CTR. Cumulative data from 4 AN patients 
and 3 CTR subjects expressed as mean ± SEM, statistical analysis by Mann 
Whitney test. (**p≤0.01; * p≤0.03; ns=not significant). 
 
3.6 Evaluation of antioxidant status in PBMCs and in human fibroblasts 
cultured with AN or control serum  
As shown in Figure 10, 14 genes (RPLP0, ALOX12, ApoE, BNIP3, CCL5, 
DUOX2, GPX1, GPX3, MT3, PRDX2, PRDX6, PRNP, PTGS2 and RNF7) 
were significantly up-regulated (p<0.05) in PBMCs isolated from AN 
patients compared with those from control subjects (fold change range: 2-9). 
To determine whether serum from AN patients affected the cell antioxidant 
potential, we analysed the gene expression of mRNA isolated from the BJ 
human fibroblasts cultured with AN or control serum. Eighty-three of the 92 
genes were expressed in BJ fibroblasts; NOX5 and PTGS2 were significantly 
down-regulated (p=0.02 and p=0.004, respectively), while GPX3 was 
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significantly up-regulated (p=0.002) in the fibroblasts cultured with AN 
serum versus those treated with control serum (Figure 11). 
Figure 10: Significantly higher levels of antioxidant genes in PBMCs 
fromAN with respect to control subjects. (A-N) Relative amount of the 
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indicated mRNA using GAPDH as endogenous reference genein both AN 
and CTR subjects. (O) Fold change of mRNA from AN versusmRNA in CTR 
subjects.RPLP0:60S Ribosomal Protein L10;  ALOX12:Arachidonate 12-
Lipoxygenase; ApoE: Apolipoprotein E; BNIP3: BCL2/adenovirus E1B 19 
kDa protein-interacting protein 3; CCL5: chemokine (C-C motif) ligand 5; 
DUOX2: dual oxidase 2; GPX1 and GPX3: Glutathione peroxidase 1 and 3; 
MT3: Metallothionein-3; PRDX2 and PRDX6: Peroxiredoxin-2; PRNP: 
prion protein; PTGS2: prostaglandin-endoperoxide synthase 2; RNF7: ring 
finger protein 7. *: p< 0.05. 
 
Figure 11: Antioxidant gene expression in BJ cells cultured with AN or CTR 
sera. (A-C) Relative amount of the indicated mRNA using GAPDH as 
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endogenous reference gene in both AN and CTR sera cultured cells. (D) Fold 
change of mRNA from AN serum cultured cells versus mRNA measured in 
CTR serum cultured cells. GPX3: Glutathione peroxidase 3; NOX5: NADPH 
oxidase, EF-hand calcium binding domain 5; PTGS2: prostaglandin-
endoperoxide synthase 2. *:p= 0.02; **: p=0.002; ***: p=0.004. 
 
3.7 Sera from AN patients enhanced stress resistance to hydrogen 
peroxide in human fibroblasts 
To determine the effect induced by AN and control sera on resistance to 
oxidative stress, we cultured BJ cells for 48 hours with AN or control sera 
and then exposed them to increasing concentrations of the powerful 
oxidizing agent, H2O2 for 24 hours. H2O2 induced a dose-dependent decline 
in survival, but fibroblasts cultured with AN serum were significantly 
protected from the cytotoxic effect of the oxidant (Figure 12). In fact, at 200 
µM H2O2, 73% of cells pretreated with AN sera versus 49% of cells 
pretreated with control sera were viable (p<0.01). The higher stress 
resistance induced by AN sera occurred also at higher H2O2 concentrations. 
In fact, the survival rates of cells pretreated with AN or control sera were 
63% vs 40% at 400µM, and 56% versus 29% at 600 µM H2O2, respectively 
(p<0.05). 
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Figure 12: Sera from AN patients enhances stress resistance to hydrogen 
peroxide in human fibroblasts. AN serum cultured cells were more resistant 
to oxidative stress than CTR serum cultured cells. The solid and the dotted 
lines represent the percentage of survival of BJ cells cultured with AN or 
CTR serum, respectively, after treatment with increasing doses of H2O2. 
*:p<0.05; **: p<0.01. 
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4. DISCUSSION 
4.1 First Aim  
We report here that some molecular and functional adaptations of CR, such 
enhanced stress resistance, can be mimicked in vitro by culturing cells with 
serum from individuals practicing long-term CR without malnutrition. Our 
findings show that the incubation of human fibroblasts with CR sera induces 
a transcriptional activation of several anti-oxidant genes along the Nrf2 
pathway. In addition, we found that the incubation of fibroblasts with human 
CR serum is sufficient to increase stress resistance to hydrogen peroxide in 
vitro. These molecular and cellular adaptations are consistent with findings 
in CR rodents and monkeys, and may contribute at least in part to the 
protective anti-aging effects of CR (Anderson et al 2009, Lee et al 1999). In 
particular, accumulating data indicate that aging is associated with a down-
regulation of stress-response genes and pathways (Lee et al 1999). To test the 
hypothesis that CR can counteract some of these age-associated detrimental 
effects in vitro, we first sought to determine if circulating factors of CR sera 
modify gene expression profiles of fibroblasts, which are the most abundant 
cell type in connective tissues and form the structural framework of tissues 
through their secretion of extracellular matrix components. To this end, we 
cultured human primary fibroblasts with sera from 12 middle-aged (57.8±8.4 
yrs), weight-stable very lean (BMI=19.1±1.2 kg/m2) individuals who have 
been practicing ~30% CR with adequate nutrition (at least 100% of RDI for 
each nutrient), for 3-20 years, and a control group of 13 non-obese 
(BMI=25.7±2.3 kg/m2) age-matched sedentary controls eating a typical 
Western diet. Remarkably, we found that culturing cells with human CR sera 
	   56	  
for 48-hrs was sufficient to trigger a rapid transcriptional up-regulation of 
important genes and pathways that control stress resistance. In particular, we 
found that a highly significant number of transcripts along the Nrf2 pathway 
were altered by CR, and genes encoding important antioxidant enzymes, 
such as GSTK1, GSTT1, IDH2, GPX1 and SOD2, were up-regulated at least 
two fold in the CR group. Nrf2 is a key transcription factor that binds to the 
antioxidant response element (ARE) in response to environmental 
carcinogens or low levels of insulin, and increases the transcription of a 
variety of antioxidative and carcinogen-detoxification enzymes that boost 
protection against cellular and molecular damage and cancer (Kannan and 
Jaiswal 2006, Kim and Novak 2007, Kwak et al 2002). It might be also 
possible that CR causes oxidative stress and therefore induce a NRF2-
dependent response, supporting the hypothesis that oxidative damage is not a 
cause of aging (Gems and Partridge 2013, Gems and de la Guardia 2013, 
Blagosklonny 2012). 
In order to further investigate the role of CR sera in modifying the resistance 
of cells to oxidative stress, we next performed a series of experiments in 
which we exposed human primary fibroblasts to increasing concentrations of 
H2O2, a powerful oxidizing agent. Our data indicate that incubating 
fibroblasts with CR sera exerts a rapid and profound protection against 
hydrogen peroxide-induced cytotoxicity. These findings are consistent with 
data from studies in mice, suggesting that these selected cellular adaptations 
induced by circulating factors are conserved among species (de Cabo et al 
2003). Indeed, most of the metabolic and hormonal parameters examined in 
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CR humans are similar to those reported in CR rodents (Cangemi et al 2010, 
Fontana and Klein 2007, Fontana et al 2010 b). 
In conclusion, our findings reported here show that enhanced stress 
responsiveness known to occur in animals on CR following oxidative stress 
can be reproduced in vitro by culturing cells using serum from CR patients. 
Our findings provide support for a possible neuroendocrine based 
mechanism of CR and offer a model for the screening and investigation of 
CR mimetic agents. We anticipate that this novel in vitro model will be 
instrumental in the elucidation of biochemical, molecular and cellular 
mechanisms underlying the anti-aging effects of CR in humans. 
4.2 Second Aim 
The data of the present study show that young AN women with 
pathologically low body weight (BMI, 15.9±0.4 kg/m2) have significantly 
lower circulating levels of leptin, IGF-1, leukocytes and lymphocytes than 
age-matched lean control subjects. In particular, we found that the T 
lymphocyte CD3+, CD3+CD45+RA+, CD4+CD28+, CD8+CD11b+, 
CD3+CD16+CD56+, and NK cell CD3-CD16+CD56+ subpopulations were 
significantly lower in the AN patients than in control subjects. Moreover, the 
antioxidant potential and the anti-inflammatory status were more efficient in 
the PBMCs of AN patients than in controls.  
Leptin is one of the key adipokines secreted by adipocytes (Engineer and 
Garcia 2012) that affects both innate and adaptive immunity (Galgani et al 
2010) and exerts differential effects on several T-cell subpopulations by 
activating the mammalian target of the rapamycin (mTOR) pathway (De 
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Rosa et al 2007, Procaccini et al 2012, Procaccini et al 2010). In particular, 
leptin inhibits Treg proliferation (De Rosa et al 2007), whereas it enhances 
conventional T-cells (Tconv) proliferation (Procaccini et al 2012). The 
enhanced proliferation of CD4+CD25- Tconv is associated with inflammatory 
cytokine secretion, whereas leptin neutralization has the opposite effect, 
suggesting that this adipokine plays a key role in T-cell homeostasis and 
function (Conde et al 2010, Matarese and La Cava 2007). Accordingly, it has 
been reported that women with hypothalamic amenorrhea and concurrent 
chronic-acquired relative leptin deficiency have a reduced number and 
function of T cells, which are restored after leptin treatment (Matarese et al 
2013). In animal models, leptin reduced the number of natural killer cells in 
isolated fat pads (La cava and Matarese 2004). In line with these data, the 
number of circulating natural killer (CD3-CD16+CD56+) cells was reduced in 
our AN patients. 
Leptin levels were severely lower in our AN patients than in controls (∼1 vs 
15 ng/mL), which coincides with previous reports (Terra et al 2013, 
Dostálová et al 2007, Modan-Moses et al 2007, Janas-Kozik 2011, Föcker et 
al 2011). In physiological conditions, low leptin levels trigger a 
compensatory increase in food intake and a decrease in energy expenditure, 
but this mechanism is deranged in AN subjects possibly because of 
decreased transport of leptin through the blood-to-brain barrier induced by 
food deprivation (Kastin et al 2000).  
Adiponectin was significantly higher in our AN patients than in control 
subjects, in accordance with previous studies (Pannacciulli et al 2003, 
Delporte et al 2003, Terra et al 2013, Dostálová et al 2007). The enhanced 
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adiponectin levels in AN patients could result from loss of the negative 
feedback physiologically exerted by fat depots on their own adiponectin 
production, or from the altered sympathetic nervous tone (Delporte et al 
2003). In line with the latter hypothesis, 24h urinary catecholamine was 
reduced in our AN patients, and could have induced the increase of serum 
adiponectin levels. 
Parallel to hyperadiponectinemia, insulin levels were very low in our AN 
patients in the presence of normoglycemia, which coincides with increased 
insulin sensitivity in AN subjects (Terra et al 2013, Dostálová et al 2007, 
Modan-Moses et al 2007). Accordingly, the leptin:adiponectin ratio that we 
previously identified as a marker of insulin resistance (Labruna et al 2011), 
was significantly lower in AN than in control subjects. 
Adiponectin exerts anti-inflammatory effects by down-regulating the 
expression of pro-inflammatory molecules such as TNF-α and IL-6, and 
stimulating the secretion of anti-inflammatory cytokines like IL-10 (Ouchi et 
al 2011, Holland et al 2013).  Its secretion is modulated by IL-6, which in 
turn inhibits adiponectin synthesis. Accordingly, levels of IL-6 and TNF-α 
were higher in HS-cultured AN PBMCs than in controls. This secretion was 
abolished in AS-cultured PBMCs, which suggests that serum adiponectin 
indirectly affects IL-6 and TNF-α secretion. Moreover, despite lower pro-
inflammatory cytokine secretion (IL-1β, TNF-α, IL-6) in supernatants of 
stimulated AS-cultured AN PBMCs, T-cell proliferation did not differ 
between HS and AS-cultured PBMCs in our AN patients and control 
subjects. Interestingly rAN patients had also lower levels of sTNF-R1 than 
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control subjects. Since the soluble forms of TNF receptors (sTNF-Rs) can be 
considered a marker of activation of immune system (Spoettl et al 2007), our 
data suggest that decreased levels of sTNF-R1 in rAN patients, is associated 
with an anti-inflammatory immune response. 
Recent findings have expanded our knowledge of how aspects of cellular 
metabolism can modulate several T cell responses thereby controlling the 
fine balance between inflammation and immune tolerance (Pearce et al 
2013).  Consequently, we investigated the bioenergetic profile of AN and 
control PBMCs in unstimulated and stimulated conditions by studying 
ECAR and OCR, the two major energy-producing pathways essential for the 
functions of all living cells, including immune cells (Pearce et al 2013). 
Interestingly, we found, for the first time, lower glycolysis and mitochondrial 
respiration in AN PBMCs compared with healthy controls both in basal 
condition and after anti-CD3 stimulation, which suggests impaired 
bioenergetic metabolism in AN immune cells. However, maximal respiration 
did not differ between AN and control T cells, suggesting that the former are 
able to compensate the mitochondrial functional deficit in response to 
increased metabolic demand. The afore-mentioned data indicate that T cells 
from AN patients are bioenergetically different from those of control 
subjects. In fact, they are metabolically less active, which indicates that 
caloric deprivation could play a role in modulation of the cellular metabolic 
machinery. These results are in line with experimental data showing that 
activated T cells have high metabolic demands, associated with increased 
glycolysis activation, mitochondrial activity, ATP synthesis and ROS 
production (Pearce et al 2013). Therefore, the low metabolic profile observed 
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in AN patients could justify the anti-inflammatory status characterizing AN 
patients. According to the latter hypothesis, the antioxidant status of PBMC 
of our AN patients was enhanced. In particular, genes encoding the 
antioxidant enzymes GPX1, GPX3, PRDX2, PRDX6 and DUOX2 were 
significantly up-regulated (between 4-8 fold). To determine whether 
circulating factors of AN sera could be responsible for this enhanced 
antioxidant status, we evaluated the antioxidant profile of fibroblasts, which 
are the most abundant cell type in connective tissues, cultured with AN or 
control sera. We found that 48h of culture with AN serum was sufficient to 
induce the expression of GPX3 and to down-regulate NOX5, an enzyme that 
generates superoxide. These data are consistent with data obtained in 
individuals on long-term calorie restriction that have also increased levels of 
serum adiponectin (Omodei et al 2013, Fontana et al 2010 b).  
To probe further the effect exerted by AN sera on the antioxidant response, 
we challenged fibroblasts cultured with AN and control sera with increasing 
doses of H2O2. Our data indicate that AN serum confers protection against 
the cytotoxic effect of H2O2. This effect could be explained by the high 
plasma adiponectin concentrations in our patients and by the high 
assumption of vitamin and antioxidant-rich foods. Interestingly, adiponectin 
ensured normal oxidative stress levels and glutathione levels in cells exposed 
to oxidized low-density lipoprotein (Plant et al 2008). Moreover, a positive 
association between plasma adiponectin levels and glutathione was also 
described in elderly individuals (Gustafsson et al 2013). However, further 
studies are required to determine whether or not adiponectin is responsible 
for the enhanced antioxidant and anti-inflammatory status of AN patients. 
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In summary, here we demonstrated that AN patients have lower leptin and 
IGF-1, and higher adiponectin serum levels; the analysis of lymphocyte 
subpopulations also showed, although in the normal range, fewer leucocytes, 
lymphocytes, CD3+ and NK cells. Moreover, AN patients showed an 
impaired bioenergetic metabolism, as evidenced by lower glycolysis and 
mitochondrial respiration than in controls. Furthermore, an increased 
antioxidant potential was described in AN patients, either in terms of 
increased antioxidant gene expression in PBMCs or as augmented resistance 
to oxidative stress of human fibroblasts cultured with AN sera. 
In conclusion, our data suggest that excessive CR in AN patients is 
associated with a reduction in several key immune cell populations, impaired 
metabolic activity, but preserved immune function. Moreover, our findings 
suggest that chronic severe CR in young AN patients results in an enhanced 
anti-oxidant and anti-inflammatory status, which may protect cells from 
biochemical stress. 
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